Search

Tricuspid Valve Repair for Treatment and Prevention of Secondary Tricuspid Regurgitation in Patients Undergoing Mitral Valve Surgery

Ani C. Anyanwu, MD, Joanna Chikwe, MD and David H. Adams, MD

Secondary or functional tricuspid regurgitation occurring late after mitral valve surgery is associated with high morbidity and mortality. In this article, we review the pathophysiology of secondary tricuspid regurgitation and the evidence supporting the use of tricuspid valve annulopla...

March 01, 2008 | Current Cardiology Reports
Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions

Cary W. Akins MD Craig Miller MD, Marko I. Turina MD, Nicholas T. Kouchoukos MD, Eugene H. Blackstone MD, Gary L. Grunkemeier PhD, Johanna J.M. Takkenberg MD, PhD, Tirone E. David MD, Eric G. Butchart MD, David H. Adams MD, David M. Shahian MD, Siegfried

The Councils of The American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The European Association for Cardio-Thoracic Surgery have directed an Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity to review current clinica...

April 01, 2008 | The Journal of Thoracic and Cardiovascular Surgery
The Cardiologist's Role in Increasing the Rate of Mitral Valve Repair in Degenerative Disease

David H. Adams, MD and Ani C. Anyanwu, MD

In the hands of reference mitral valve-repair surgeons, 95-100% of degenerative valves are repairable, regardless of etiology; however, in the general cardiac surgical community, the repair rates are around 50%. In contrast to fibroelastic deficiency, Barlow's valves have more complex p...

March 01, 2008 | Current Opinion in Cardiology
Degenerative Mitral Valve Disease

David H. Adams, MD, Guest Editor

Degenerative Mitral Valve Disease: Introduction David H. Adams introduction.pdf Principles of Reconstructive Surgery in Degenerative Mitral Valve Disease Farzan Filsoufi, Alain Carpentier Degenerative mitral valve disease is the most common ...

July 01, 2007 | Seminars in Thoracic and Cardiovascular Surgery
The Intraoperative “Ink Test”: A Novel Assessment Tool in Mitral Valve Repair

Ani C. Anyanwu and David H. Adams

Mitral valve repair is the established therapy of choice for most patients with mitral regurgitation. Assessment of repair quality traditionally relies on visual inspection, saline testing, and transesophageal echocardiography (TEE). Although invaluable in assessing valve competency, th...

June 01, 2007 | The Journal of Thoracic and Cardiovascular Surgery
Large Annuloplasty Rings Facilitate Mitral Valve Repair in Barlow’s Disease

David H. Adams, Ani C. Anyanwu, Parwis B. Rahmanian, Vivian Abascal, Sacha P. Salzberg, Farzan Filsoufi

Mitral valve repair can be predictably performed in Barlow's disease with excellent early outcomes. Large annuloplasty rings help minimize the risk of systolic anterior motion and are an important adjunct to established repair techniques in this patient cohort with large annular size an...

December 01, 2006 | The Annals of Thoracic Surgery
Physiologic Basis for the Surgical Treatment of Ischemic Mitral Regurgitation

Farzan Filsoufi, Parwis B. Rahmanian, Ani Anyanwu, David H. Adams

Ischemic mitral regurgitation (MR) can complicate severe coronary artery disease and myocardial infarction. Ischemic MR results from left ventricular remodeling after myocardial infarction and can also accompany acute myocardial ischemia. The most common mechanism of ischemic MR is Carp...

September 01, 2006 | The American Heart Hospital Journal
Bioprosthetic aortic valve replacement: revisiting prosthesis choice in patients younger than 50 years old

Samuel R. Schnittman, MD, David H. Adams, MD, Shinobu Itagaki, MD, Nana Toyoda, MD, Natalia N. Egorova, PhD, Joanna Chikwe, MD

OBJECTIVE: Aortic prosthesis choice is controversial in young adults because robust comparative outcome data are lacking. We therefore compared mortality and morbidity in young adults after bioprosthetic versus mechanical aortic valve replacement. METHODS: This was a retrospective an...

September 13, 2017 | The Journal of Thoracic and Cardiovascular Surgery
Real world outcomes of surgery for native mitral valve endocarditis

Samuel R. Schnittman, MD, David H. Adams, MD, Shinobu Itagaki, MD, Nana Toyoda, MD, Natalia N. Egorova, PhD, Joanna Chikwe, MD

BACKGROUND: Consensus guidelines recommend repair over replacement for the surgical treatment of active native mitral valve infective endocarditis. However, contemporary practice and long-term outcome data are limited. METHODS: Multivariable Cox regression was used to compare outcome...

August 30, 2017 | The Journal of Thoracic and Cardiovascular Surgery
Survival and long-term outcomes after mitral valve replacement in patients aged 18 to 50 years

Samuel R. Schnittman, MD, David H. Adams, MD, Shinobu Itagaki, MD, Nana Toyoda, MD, Natalia N. Egorova, PhD, Joanna Chikwe, MD

OBJECTIVE: To provide long-term data on survival and major morbidity after mitral valve replacement in patients aged 18 to 50 years. METHODS: Retrospective analysis of 2727 patients aged 18 to 50 years who underwent isolated mitral replacement in California and New York from 1997 to ...

August 30, 2017 | The Journal of Thoracic and Cardiovascular Surgery

Mitral Valve Repair Center

at The Mount Sinai Hospital

Tricuspid Valve Repair for Treatment and Prevention of Secondary Tricuspid Regurgitation in Patients Undergoing Mitral Valve Surgery

Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions

The Cardiologist's Role in Increasing the Rate of Mitral Valve Repair in Degenerative Disease

Degenerative Mitral Valve Disease

The Intraoperative “Ink Test”: A Novel Assessment Tool in Mitral Valve Repair

Large Annuloplasty Rings Facilitate Mitral Valve Repair in Barlow’s Disease

Physiologic Basis for the Surgical Treatment of Ischemic Mitral Regurgitation

Bioprosthetic aortic valve replacement: revisiting prosthesis choice in patients younger than 50 years old

Real world outcomes of surgery for native mitral valve endocarditis

Survival and long-term outcomes after mitral valve replacement in patients aged 18 to 50 years